• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Egyptian Journal of Hospital Medicine
Articles in Press
Current Issue
Journal Archive
Volume Volume 77 (2019)
Volume Volume 76 (2019)
Volume Volume 75 (2019)
Volume Volume 74 (2019)
Volume Volume 73 (2018)
Volume Volume 72 (2018)
Volume Volume 71 (2018)
Volume Volume 70 (2018)
Volume Volume 69 (2017)
Volume Volume 68 (2017)
Volume Volume 67 (2017)
Volume Volume 66 (2017)
Volume Volume 65 (2016)
Volume Volume 64 (2016)
Volume Volume 63 (2016)
Issue Issue 1
Volume Volume 62 (2016)
Volume Volume 61 (2015)
Volume Volume 60 (2015)
Volume Volume 59 (2015)
Volume Volume 58 (2015)
Volume Volume 57 (2014)
Volume Volume 56 (2014)
Volume Volume 55 (2014)
Volume Volume 54 (2014)
Volume Volume 53 (2013)
Volume Volume 52 (2013)
Volume Volume 51 (2013)
Volume Volume 50 (2013)
Volume Volume 49 (2012)
Volume Volume 48 (2012)
Volume Volume 47 (2012)
Volume Volume 46 (2012)
Volume Volume 45 (2011)
Volume Volume 44 (2011)
Volume Volume 43 (2011)
Volume Volume 42 (2011)
Volume Volume 41 (2010)
Volume Volume 40 (2010)
Volume Volume 39 (2010)
Volume Volume 38 (2010)
Volume Volume 37 (2009)
Volume Volume 36 (2009)
Volume Volume 35 (2009)
Volume Volume 34 (2009)
Volume Volume 33 (2008)
Volume Volume 32 (2008)
Volume Volume 31 (2008)
Volume Volume 30 (2008)
Volume Volume 29 (2007)
Volume Volume 28 (2007)
Volume Volume 27 (2007)
Volume Volume 26 (2007)
Volume Volume 25 (2006)
Volume Volume 24 (2006)
Volume Volume 23 (2006)
Volume Volume 22 (2006)
Volume Volume 21 (2005)
Volume Volume 20 (2005)
Volume Volume 19 (2005)
Volume Volume 18 (2005)
Volume Volume 17 (2004)
Volume Volume 16 (2004)
Volume Volume 15 (2004)
Volume Volume 14 (2004)
Volume Volume 13 (2003)
Volume Volume 12 (2003)
Volume Volume 11 (2003)
Volume Volume 10 (2003)
Volume Volume 9 (2002)
Volume Volume 8 (2002)
Volume Volume 7 (2002)
Volume Volume 6 (2002)
Volume Volume 5 (2001)
Volume Volume 4 (2001)
Volume Volume 3 (2001)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
El Nashar, N., Hatem, M. (2018). Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer. The Egyptian Journal of Hospital Medicine, 63(1), 206-209. doi: DOI: 10.12816/0023846
Nihad El Nashar; Mohamed Hatem. "Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer". The Egyptian Journal of Hospital Medicine, 63, 1, 2018, 206-209. doi: DOI: 10.12816/0023846
El Nashar, N., Hatem, M. (2018). 'Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer', The Egyptian Journal of Hospital Medicine, 63(1), pp. 206-209. doi: DOI: 10.12816/0023846
El Nashar, N., Hatem, M. Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer. The Egyptian Journal of Hospital Medicine, 2018; 63(1): 206-209. doi: DOI: 10.12816/0023846

Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer

Article 9, Volume 63, Issue 1, Spring 2016, Page 206-209  XML PDF (120.22 K)
Document Type: Original Article
DOI: DOI: 10.12816/0023846
Authors
Nihad El Nashar; Mohamed Hatem
College of Medicine, Taif University PO Box 888, Taif 21947, Kingdom of Saudi Arabia
Abstract
Background and aim of the work: Previous studies verified that Endostatin, matrix metalloproteinase (MMP) -2 and -9, in addition to tissue inhibitors of metalloproteinase (TIMP) -1 may play a crucial role in prognosis of non-small cell lung cancer (NSCLC). In this study we will investigate the changes in the pretreatment serum levels of these factors and to evaluate their clinical implication in patients with advanced non-small cell lung cancer (NSCLC).
Patients and methods: Pretreatment serum samples were collected from 25 patients and 10 control healthy individuals. The levels of Endostatin, MMP-2, MMP-9, and TIMP-1 were measured using a sandwich enzyme immunoassay kit.
Results: The pretreatment serum levels of Endostatin and TIMP1 were significantly elevated and correlated with their stages and survival (P< 0.05), where, the serum level of Endostatin in healthy subjects was 81.20±23.99 ng/ml and in patients with NSCLC was 354.40 ± 164.01 ng/ml. The serum level of TIMP1 in healthy subjects was 1.49±0.29 ng/ml and in patients with NSCLC was 2.96±0.58 ng/ml. The serum level of MMP2 and 9 were non-significantly decreased in serum of NSCLC patients (P > 0.05), where the serum activity of MMP2 in healthy subjects was 0.14±0.03 ng/ml and in patients with NSCLC was 0.09±0.03 % and the serum activity of MMP9 in healthy subjects was 0.13±0.019 ng/ml and in patients with NSCLC was 0.10±0.03 %.
 Conclusions: Our results indicated that the circulating levels of Endostatin, and TIMP-1 in patients with NSCLC may be valuable future tools for treatment planning and monitoring of treatment, however, these blood tests need to be standardized and validated in large-scale prospective clinical trials.
 
Keywords
Endostatin; Matrix metalloproteinase; tissue inhibitors of metalloproteinase; non small cell lung cancer
Statistics
Article View: 9
PDF Download: 5
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.